Recent posts
Sunnyvale, California – February 9, 2022 Gener8 LLC (“Gener8”), a portfolio company of Sverica Capital Management LP (“Sverica”), welcomes Mark Chatfield as the new Global Vice President of Operations. Mark brings thirty years of experience with Thermo Fisher Scientific running operations in the fields of specialized x-rays, chromatography, and mass…
Read more
Sunnyvale, California – December 9, 2021 Gener8 LLC (“Gener8”), a portfolio company of Sverica Capital Management LP (“Sverica”), announced today that it has completed its acquisition of the RND Group (“RND”), a leading provider of software development focused on medical device and life science products, based in Indianapolis, Indiana. With…
Read more
SUNNYVALE, Calif., June 30, 2021, Gener8 LLC (“Gener8”), a provider of full product lifecycle engineering and manufacturing solutions for highly complex instruments and products within the life sciences and medical device markets, together with its capital partner, Sverica Capital Management LP, is restructuring its 15,000 sq. ft. Carlsbad facility to provide microfluidics cartridge design,…
Read more
SUNNYVALE, Calif., June 17, 2021 — Gener8 LLC (“Gener8”), a provider of full product lifecycle engineering and manufacturing solutions for highly complex instruments and products within the life sciences and medical device markets, together with its capital partner, Sverica Capital Management LP, announced today that it has expanded its services…
Read more
Sunnyvale, California, March 25, 2021 – Gener8 LLC, a provider of full product lifecycle engineering and manufacturing solutions for highly complex instruments and products within the life sciences and medical device markets, together with its capital partner, Sverica Capital Management LP, announced today the placement of Jerry Jurkiewicz as Chief…
Read more